"This is one of the biggest shifts of multiple responsibilities across multiple programs at the same time that I’ve seen," ...
"This is one of the biggest shifts of multiple responsibilities across multiple programs at the same time that I’ve seen,” ...
Johnson & Johnson today announced findings from the Phase 2 DAHLIAS study published in The Lancet showing that nipocalimab, an investigational FcRn treatment for Sjögren's disease (SjD), significantly ...
Canada has long celebrated its identity as a welcoming nation, but recent immigration targets have stirred debate across the ...